Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Philpot

Showing results (121-130 of 136) with videos related to

Pageof 14
Sort By:
Nature Communications|July 8, 2024
Ube3a unsilencer for the potential treatment of Angelman syndromeHanna Vihma, Kelin Li, Anna Welton-Arndt, et al.
Biological Psychiatry|March 4, 2019
Electrophysiological Phenotype in Angelman Syndrome Differs Between GenotypesJoel Frohlich, Meghan T Miller, Lynne M Bird, et al.
Nature|December 23, 2011
Topoisomerase inhibitors unsilence the dormant allele of Ube3a in neuronsHsien-Sung Huang, John A Allen, Angela M Mabb, et al.
Nature|February 3, 2026
Ontogeny and transcriptional regulation of Thetis cellsYoselin A Paucar Iza, Tyler Park, Eliyambuya Baker, et al.
Neuron|June 5, 2018
The Temporal Dynamics of Arc Expression Regulate Cognitive FlexibilityMark J Wall, Dawn R Collins, Samantha L Chery, et al.
Nature|June 16, 2026
Author Correction: Ontogeny and transcriptional regulation of Thetis cellsYoselin A Paucar Iza, Tyler Park, Eliyambuya Baker, et al.
Nature Reviews. Drug Discovery|May 18, 2021
Clinical trial strategies for rare neurodevelopmental disorders: challenges and opportunitiesMichelle L Krishnan, Elizabeth Berry-Kravis, Jamie K Capal, et al.
Journal of Neurodevelopmental Disorders|March 7, 2026
Crossing the finish line towards a disease-modifying treatment for Angelman syndromeMatthew C Judson, Luis Pereira de Almeida, Rebecca D Burdine, et al.
JCI Insight|September 22, 2022
Molecular and behavioral consequences of Ube3a gene overdosage in miceA Mattijs Punt, Matthew C Judson, Michael S Sidorov, et al.
Human Molecular Genetics|May 12, 2011
Synaptic dysfunction and abnormal behaviors in mice lacking major isoforms of Shank3Xiaoming Wang, Portia A McCoy, Ramona M Rodriguiz, et al.
Pageof 14

Showing results (121-130 of 136) with videos related to

Sort By:
Pageof 14
Nature Communications|July 8, 2024
Ube3a unsilencer for the potential treatment of Angelman syndromeHanna Vihma, Kelin Li, Anna Welton-Arndt, et al.
Biological Psychiatry|March 4, 2019
Electrophysiological Phenotype in Angelman Syndrome Differs Between GenotypesJoel Frohlich, Meghan T Miller, Lynne M Bird, et al.
Nature|December 23, 2011
Topoisomerase inhibitors unsilence the dormant allele of Ube3a in neuronsHsien-Sung Huang, John A Allen, Angela M Mabb, et al.
Nature|February 3, 2026
Ontogeny and transcriptional regulation of Thetis cellsYoselin A Paucar Iza, Tyler Park, Eliyambuya Baker, et al.
Neuron|June 5, 2018
The Temporal Dynamics of Arc Expression Regulate Cognitive FlexibilityMark J Wall, Dawn R Collins, Samantha L Chery, et al.
Nature|June 16, 2026
Author Correction: Ontogeny and transcriptional regulation of Thetis cellsYoselin A Paucar Iza, Tyler Park, Eliyambuya Baker, et al.
Nature Reviews. Drug Discovery|May 18, 2021
Clinical trial strategies for rare neurodevelopmental disorders: challenges and opportunitiesMichelle L Krishnan, Elizabeth Berry-Kravis, Jamie K Capal, et al.
Journal of Neurodevelopmental Disorders|March 7, 2026
Crossing the finish line towards a disease-modifying treatment for Angelman syndromeMatthew C Judson, Luis Pereira de Almeida, Rebecca D Burdine, et al.
JCI Insight|September 22, 2022
Molecular and behavioral consequences of Ube3a gene overdosage in miceA Mattijs Punt, Matthew C Judson, Michael S Sidorov, et al.
Human Molecular Genetics|May 12, 2011
Synaptic dysfunction and abnormal behaviors in mice lacking major isoforms of Shank3Xiaoming Wang, Portia A McCoy, Ramona M Rodriguiz, et al.
Pageof 14